Your browser is no longer supported. Please, upgrade your browser.
PROG Progenity, Inc. daily Stock Chart
Progenity, Inc.
Index- P/E- EPS (ttm)-4.83 Insider Own32.80% Shs Outstand40.95M Perf Week15.91%
Market Cap378.79M Forward P/E- EPS next Y- Insider Trans- Shs Float30.72M Perf Month-
Income-218.30M PEG- EPS next Q- Inst Own- Short Float- Perf Quarter-
Sales113.30M P/S3.34 EPS this Y-77.20% Inst Trans- Short Ratio- Perf Half Y-
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year-
Cash/sh0.28 P/C32.65 EPS next 5Y- ROE- 52W Range7.63 - 15.92 Perf YTD-29.50%
Dividend- P/FCF- EPS past 5Y- ROI1315.20% 52W High-41.90% Beta-
Dividend %- Quick Ratio1.00 Sales past 5Y- Gross Margin9.40% 52W Low21.23% ATR1.35
Employees676 Current Ratio1.10 Sales Q/Q-64.60% Oper. Margin- RSI (14)- Volatility11.67% -
OptionableNo Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.21 Prev Close10.05
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume547.36K Price9.25
Recom- SMA20-8.98% SMA50-8.98% SMA200-8.98% Volume123,117 Change-7.96%
Jun-19-20 09:29AM  
Progenity, Inc., a biotechnology company, provides complex molecular and specialized testing services to physicians, clinicians, and their patients in the United States. It offers testing services for common hereditary disorders, cystic fibrosis, spinal muscular atrophy, fragile X syndrome, and Jewish genetic diseases; pan-ethnic carrier screening services; non-invasive prenatal, miscarriage, and pharmacogenetic testing services; and ovarian assessment reports for women. The company also provides pediatric testing services. Progenity, Inc. was formerly known as Ascendant MDX, Inc. and changed its name to Progenity, Inc. in November, 2013. The company was incorporated in 2012 and is based in San Diego, California with a laboratory in Ann Arbor, Michigan. It has a bill payment location in Detroit, Michigan.